Is there a generic for Cyclacillin?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Cyclacillin, referencing the brand CYCLAPEN-W. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Cyclacillin?

CYCLAPEN-W (NDA 050508, WYETH AYERST) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cyclacillin are approved?

Cyclacillin is approved in the following dosage forms: for suspension, tablet.

FDA Orange Book · active-ingredient family

Cyclacillin

Cyclacillin is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CYCLAPEN-W · NDA 050508

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · for suspension, tablet

Product	Applicant	Application	TE	Approved
CYCLAPEN-W×3	WYETH AYERST	NDA 050508	—	Approved Prior to Jan 1, 1982
CYCLAPEN-W×2	WYETH AYERST	NDA 050509	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
CYCLACILLIN×2	TEVA	ANDA 062895	—	Aug 04, 1988

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cyclacillin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo